Deutsche Bank Downgrades Moderna to Sell
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst Emmanuel Papadakis has downgraded Moderna (NASDAQ:MRNA) from Hold to Sell.
November 02, 2023 | 3:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Moderna's stock has been downgraded from Hold to Sell by Deutsche Bank.
The downgrade from Deutsche Bank is a negative signal for Moderna's stock. It suggests that the bank's analysts believe the stock's price may decrease in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100